Literature DB >> 23751614

Adenoid cystic carcinoma of the head and neck: a single-center analysis of 105 consecutive cases over a 30-year period.

Stijn van Weert1, Elisabeth Bloemena, Isaäc van der Waal, Remco de Bree, Derek H F Rietveld, Joop D Kuik, C René Leemans.   

Abstract

BACKGROUND: Adenoid cystic carcinoma is a rare salivary gland malignancy with a poor disease free survival due to frequent distant metastases and late local recurrences. Previous single-center reports on outcome mostly encompass small series. In this report a relative large series of 105 cases is analyzed, all treated at the VU University Medical Center, Amsterdam, The Netherlands over a 30-year period in which treatment strategies remained unchanged.
METHODS: All cases of ACC of the head and neck between 1979 and 2009 at our institution were analyzed through a medical chart review. Recurrence patterns and possible prognostic factors (T-stage, N-status, age, gender, type of salivary gland involved, histological grade, surgical margins, perineural invasion (PNI) and postoperative radiotherapy (RT)) were analyzed.
RESULTS: One-hundred and five cases of ACC of the head and neck were identified. Five-, ten- and twenty-year survival rates for overall survival were 68%, 52% and 28%, respectively. T-stage, N-status, surgical margins, histological subtype and age were highly significant predictors for survival. PNI was not a negative prognosticator.
CONCLUSIONS: T-stage, N-status, surgical margins, histological grade and age are the main predictors of survival-outcome in ACC of the head and neck. Distant metastasis frequently develop, mainly in the first 5 years post treatment. Local recurrences often develop even later on, warranting long term follow up of patients treated for ACC. Grade III ACC should be considered a specific entity within the group of ACC due to its typical aggressive biological behavior and relatively poor outcome, implicating the need for an improved adjuvant treatment.
Copyright © 2013. Published by Elsevier Ltd.

Entities:  

Keywords:  Adenoid cystic carcinoma; Histology; Prognosticator; Surgical margins; Survival; Tumor stage

Mesh:

Year:  2013        PMID: 23751614     DOI: 10.1016/j.oraloncology.2013.05.004

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  41 in total

1.  Pattern of recurrent disease in major salivary gland adenocystic carcinoma.

Authors:  Karoliina Hirvonen; Leif Bäck; Kauko Saarilahti; Ilmo Leivo; Jaana Hagström; Antti A Mäkitie
Journal:  Virchows Arch       Date:  2015-04-03       Impact factor: 4.064

2.  Salivary gland tumor fine-needle aspiration cytology: a proposal for a risk stratification classification.

Authors:  Christopher C Griffith; Reetesh K Pai; Frank Schneider; Umamaheswar Duvvuri; Robert L Ferris; Jonas T Johnson; Raja R Seethala
Journal:  Am J Clin Pathol       Date:  2015-06       Impact factor: 2.493

3.  MYB Translocation Status in Salivary Gland Epithelial-Myoepithelial Carcinoma: Evaluation of Classic, Variant, and Hybrid Forms.

Authors:  Justin A Bishop; William H Westra
Journal:  Am J Surg Pathol       Date:  2018-03       Impact factor: 6.394

4.  When is surgical therapy for head and neck malignant epithelial tumors not indicated?

Authors:  Carlos Suárez; Robert P Takes; Carl E Silver; Juan P Rodrigo; Primož Strojan; Julia A Woolgar; Missak Haigentz; H Hakan Coskun; Remco de Bree; Randall P Owen; Mohamed N Elsheikh; Ashok R Shaha; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-04       Impact factor: 2.503

5.  Clinicopathological review and survival characteristics of adenoid cystic carcinoma.

Authors:  Fariba Binesh; Ali Akhavan; Omid Masumi; Abbas Mirvakili; Nasim Behniafard
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-08-05

Review 6.  Cervical lymph node metastasis in adenoid cystic carcinoma of oral cavity and oropharynx: A collective international review.

Authors:  Carlos Suárez; Leon Barnes; Carl E Silver; Juan P Rodrigo; Jatin P Shah; Asterios Triantafyllou; Alessandra Rinaldo; Antonio Cardesa; Karen T Pitman; Luiz P Kowalski; K Thomas Robbins; Henrik Hellquist; Jesus E Medina; Remco de Bree; Robert P Takes; Andrés Coca-Pelaz; Patrick J Bradley; Douglas R Gnepp; Afshin Teymoortash; Primož Strojan; William M Mendenhall; Jean Anderson Eloy; Justin A Bishop; Kenneth O Devaney; Lester D R Thompson; Marc Hamoir; Pieter J Slootweg; Vincent Vander Poorten; Michelle D Williams; Bruce M Wenig; Alena Skálová; Alfio Ferlito
Journal:  Auris Nasus Larynx       Date:  2016-03-24       Impact factor: 1.863

7.  Adenoid cystic carcinoma of head and neck: clinical predictors of outcome from a Canadian centre.

Authors:  J J Ko; J E Siever; D Hao; R Simpson; H Y Lau
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

8.  Long-term local control rates of patients with adenoid cystic carcinoma of the head and neck managed by surgery and postoperative radiation.

Authors:  Safina Ali; Frank L Palmer; Nora Katabi; Nancy Lee; Jatin P Shah; Snehal G Patel; Ian Ganly
Journal:  Laryngoscope       Date:  2017-03-21       Impact factor: 3.325

9.  Oropharyngeal adenoid cystic carcinoma invading the mandibular bone through the mandibular foramen.

Authors:  Yohei Takeshita; Shunsuke Okada; Miki Hisatomi; Hidenobu Matsuzaki; Hotaka Kawai; Yohei Noda; Jun Murakami; Mariko Fujita; Hitoshi Nagatsuka; Yoshinobu Yanagi; Junichi Asaumi
Journal:  Oral Radiol       Date:  2018-11-15       Impact factor: 1.852

10.  Adenoid Cystic Carcinoma in a Mexican Population.

Authors:  Kuauhyama Luna-Ortiz; Veronica Villavicencio-Valencia; Alfredo Rodríguez-Falconi; Nathalie Peteuil; Adalberto Mosqueda-Taylor
Journal:  J Maxillofac Oral Surg       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.